Search

Your search keyword '"Springer, Simeon"' showing total 61 results

Search Constraints

Start Over You searched for: Author "Springer, Simeon" Remove constraint Author: "Springer, Simeon" Database Unpaywall Remove constraint Database: Unpaywall
61 results on '"Springer, Simeon"'

Search Results

1. A novel functional gene delivery platform based on a commensal human anellovirus demonstrates transduction in multiple tissue types

2. Data from Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression

3. Supplementary Figure 4 from Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression

4. Supplementary Figure 1 from Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression

5. Data from Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression

6. Supplementary Figure 5 from Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression

7. Supplementary Table 2 from Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression

8. Supplementary Figure 5 from Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression

9. Supplementary Figure 4 from Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression

10. Supplementary Table 1 from Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression

11. Supplementary Figure 3 from Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression

12. Supplementary Table 2 from Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression

13. Supplementary Figure 3 from Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression

14. Supplementary Figure 2 from Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression

15. Supplementary Figure 1 from Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression

16. Supplementary Table 1 from Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression

17. Supplementary Methods, Figure Legends from Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression

18. Supplementary Figure 2 from Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression

19. Supplementary Methods, Figure Legends from Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression

20. Data from TERT Promoter Mutations Occur Early in Urothelial Neoplasia and Are Biomarkers of Early Disease and Disease Recurrence in Urine

21. Data from TERT Promoter Mutations Occur Early in Urothelial Neoplasia and Are Biomarkers of Early Disease and Disease Recurrence in Urine

22. Supplementary Table 1 from TERT Promoter Mutations Occur Early in Urothelial Neoplasia and Are Biomarkers of Early Disease and Disease Recurrence in Urine

23. Supplementary Table 1 from TERT Promoter Mutations Occur Early in Urothelial Neoplasia and Are Biomarkers of Early Disease and Disease Recurrence in Urine

24. Correction to: Performance of novel non-invasive urine assay UroSEEK in cohorts of equivocal urine cytology

25. Global genome analysis reveals a vast and dynamic anellovirus landscape within the human virome

26. Intraductal Papillary Mucinous Neoplasms Arise From Multiple Independent Clones, Each With Distinct Mutations

27. Incidence and distribution of UroSEEK gene panel in a multi-institutional cohort of bladder urothelial carcinoma

28. Performance of novel non-invasive urine assay UroSEEK in cohorts of equivocal urine cytology

29. A multimodality test to guide the management of patients with a pancreatic cyst

30. Targeted sequencing of plasmacytoid urothelial carcinoma reveals frequent TERT promoter mutations

31. Correction: Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy

32. Evaluation of Liquid From the Papanicolaou Test and Other Liquid Biopsies for the Detection of Endometrial and Ovarian Cancers

33. MP65-13 UROSEEK: A NOVEL NON-INVASIVE MOLECULAR METHOD FOR EARLY DETECTION OF BLADDER CANCER

34. MP65-14 UROSEEK: A NOVEL NON-INVASIVE MOLECULAR ASSAY FOR SURVEILLANCE OF BLADDER CANCER

35. Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers

36. Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy

37. Author response: Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy

39. Non-invasive detection of bladder cancer through the analysis of driver gene mutations and aneuploidy

40. Non-invasive detection of upper tract urothelial carcinomas through the analysis of driver gene mutations and aneuploidy in urine

41. Spectrum of genetic mutations in de novo PUNLMP of the urinary bladder

43. High prevalence of TERT promoter mutations in micropapillary urothelial carcinoma

44. Diagnostic potential of tumor DNA from ovarian cyst fluid

45. Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer

46. Detection of TERT promoter mutations in primary adenocarcinoma of the urinary bladder

47. A novel approach for selecting combination clinical markers of pathology applied to a large retrospective cohort of surgically resected pancreatic cysts

48. Author response: Diagnostic potential of tumor DNA from ovarian cyst fluid

49. The potential of circulating tumor DNA (ctDNA) to reshape the design of clinical trials testing adjuvant therapy in patients with early stage cancers.

50. High prevalence of TERT promoter mutations in primary squamous cell carcinoma of the urinary bladder

Catalog

Books, media, physical & digital resources